Despite the key role USP22 plays in many types of tumours, evidence for its involvement in CCA development is completely absent and its dichotomous association with different types of tumours—high USP22 expression stimulates breast tumour growth [20], whereas impedes colorectal cancer development [21]. This evidence concerns the gene USP22 and cholangiocarcinoma.